Replicate Bioscience

Replicate Bioscience

Biotechnology, Campus Point Dr Ste 150, San Diego, , 92121, California, 10210, United States, 11-50 Employees

replicatebioscience.com

  • twitter
  • LinkedIn

Who is REPLICATE BIOSCIENCE

Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicates off-the-shelf srRNAs contain two components: viral...

Read More

map
  • 10210 Campus Point Dr Ste 150, San Diego, California, 92121, United States Headquarters: 10210 Campus Point Dr Ste 150, San Diego, California, 92121, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REPLICATE BIOSCIENCE

Replicate Bioscience Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Replicate Bioscience

Answer: Replicate Bioscience's headquarters are located at Campus Point Dr Ste 150, San Diego, , 92121, California, 10210, United States

Answer: Replicate Bioscience's official website is https://replicatebioscience.com

Answer: Replicate Bioscience's revenue is $1 Million to $5 Million

Answer: Replicate Bioscience's SIC: 8731

Answer: Replicate Bioscience's NAICS: 541714

Answer: Replicate Bioscience has 11-50 employees

Answer: Replicate Bioscience is in Biotechnology

Answer: Replicate Bioscience contact info: Phone number: Website: https://replicatebioscience.com

Answer: Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicates off-the-shelf srRNAs contain two components: virally derived genetic code to drive controlled and self-limiting amplification, and the RNA encoding therapeutic proteins. Our library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude improved performance over linear mRNA, allow for the development of treatments in applications including oncology, infectious disease, and autoimmunity. Differentiated by a team of srRNA experts, a customizable library of synthetic srRNA vectors, and end-to-end development capabilities, Replicate is uniquely positioned to finally expand the reach of RNA treatments toward widespread use in infectious disease, immuno-oncology, autoimmune disease, and more.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access